» Articles » PMID: 36348722

Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses

Overview
Journal Acta Naturae
Specialty Biology
Date 2022 Nov 9
PMID 36348722
Authors
Affiliations
Soon will be listed here.
Abstract

Accurate measurement of tumor size and margins is crucial for successful oncotherapy. In the last decade, non-invasive imaging modalities, including optical imaging using non-radioactive substrates, deep-tissue imaging with radioactive substrates, and magnetic resonance imaging have been developed. Reporter genes play the most important role among visualization tools; their expression in tumors and metastases makes it possible to track changes in the tumor growth and gauge therapy effectiveness. Oncolytic viruses are often chosen as a vector for delivering reporter genes into tumor cells, since oncolytic viruses are tumor-specific, meaning that they infect and lyse tumor cells without damaging normal cells. The choice of reporter transgenes for genetic modification of oncolytic viruses depends on the study objectives and imaging methods used. Optical imaging techniques are suitable for in vitro studies and small animal models, while deep-tissue imaging techniques are used to evaluate virotherapy in large animals and humans. For optical imaging, transgenes of fluorescent proteins, luciferases, and tyrosinases are used; for deep-tissue imaging, the most promising transgene is the sodium/iodide symporter (NIS), which ensures an accumulation of radioactive isotopes in virus-infected tumor cells. Currently, NIS is the only reporter transgene that has been shown to be effective in monitoring tumor virotherapy not only in preclinical but also in clinical studies.

Citing Articles

Oncolytic Viruses in the Era of Omics, Computational Technologies, and Modeling: Thesis, Antithesis, and Synthesis.

Menotti L, Vannini A Int J Mol Sci. 2023; 24(24).

PMID: 38139207 PMC: 10743452. DOI: 10.3390/ijms242417378.

References
1.
Belin L, Ady J, Lewis C, Marano D, Gholami S, Mojica K . An oncolytic vaccinia virus expressing the human sodium iodine symporter prolongs survival and facilitates SPECT/CT imaging in an orthotopic model of malignant pleural mesothelioma. Surgery. 2013; 154(3):486-95. PMC: 4123996. DOI: 10.1016/j.surg.2013.06.004. View

2.
Power A, Wang J, Falls T, Paterson J, Parato K, Lichty B . Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity. Mol Ther. 2006; 15(1):123-30. DOI: 10.1038/sj.mt.6300039. View

3.
Keshavarz M, Sabbaghi A, Miri S, Rezaeyan A, Arjeini Y, Ghaemi A . Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?. Cancer Cell Int. 2020; 20:131. PMC: 7178751. DOI: 10.1186/s12935-020-01219-6. View

4.
Paproski R, Forbrich A, Wachowicz K, Hitt M, Zemp R . Tyrosinase as a dual reporter gene for both photoacoustic and magnetic resonance imaging. Biomed Opt Express. 2011; 2(4):771-80. PMC: 3072120. DOI: 10.1364/BOE.2.000771. View

5.
Paroo Z, Bollinger R, Braasch D, Richer E, Corey D, Antich P . Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging. 2004; 3(2):117-24. DOI: 10.1162/15353500200403172. View